iBET Latest R&D Presented at ECI Conference: Cell Culture Engineering XIX
Reinforcing iBET's Role in Advancing Cell-based Technologies
A group of iBET scientists attended the Cell Culture Engineering (CCE) XIX Conference, held in Tucson, Arizona, USA from April 27th to May 2nd.
The conference, part of the ECI – Engineering Conferences International Program, brings together experts from academic, regulatory and industrial backgrounds to discuss the latest advances in the fields of cell culture and cell-derived molecules.
iBET contributed to the scientific program with two oral presentations:
José Escandell – “Optimization of Multispecific Antibody production: the impact of vector topology, ratio, and selection strategies for improved productivity and quality”
Marta Costa – “Improving CAR T cell potency through process control”
Top: Marta Costa, Bottom: José Escandell
In addition, four posters were also presented:
José Escandell – “Uncovering mechanisms of high rAAV production using genome-wide CRISPR screens”
António Roldão – “Enhancing production and purification of adenovirus-like particles (ADDomer) for snakebit therapy”
Margarida Serra – “A modular platform of reconstructive 3D cell models of tumor microenvironment to evaluate antibody-based therapies”
Paula Alves – “Immunocompetent human 3D liver model to accelerate AAV-based ATMP development”
The conference provided iBET scientists with the opportunity to share and discuss their latest work with the scientific community, reinforcing iBET’s role in the global R&D research network in the fields of cell and gene therapy, biologics, and advanced cell-based models.
See the full conference program here.
